Abdominal Pain in Opiate Addicted Patients and Other Industrial Opiates
Novelty in Biomedicine,
Vol. 8 No. 2 (2020),
14 June 2020
,
Page 59-62
https://doi.org/10.22037/nbm.v7i3.25283
Abstract
Background: Recognition of abdominal pain help to give better diagnostic and therapeutic approaches and prevention of unnecessary surgeries. The purpose of this study was to determine the causes of abdominal pain in opiate addicted patients and other industrial opiates.Materials and Methods: In the observational study, a cross-sectional survey was used. A total of 130 consecutive addicted patients and other industrial opiates were enrolled from Modarres Hospital, Tehran, Iran in 2017-2018. Causes of abdominal pain in them were determined and compared across the other variables.
Results: Results of this study demonstrated that the causes of abdominal pain were: defecation problems and constipation,dyspepsia, peptic ulcer disease (PUD), acute abdomen, ileus, obstruction, and biliary problems and others (9.2%, 42.3%, 14.6%, 13.1%, 10%, 7.7%, and 3.1%, respectively).A significant relationship was found between high Lead level and constipation and dyspepsia (P<0.05).
Conclusion: According to the obtained results, it may be concluded that dyspepsia and PUD are most common causes of abdominal pain in addict subjects that is similar to general population and accordingly therapeutic approaches in addict subjects should be similar to the general population.- Abdominal Pain
- Addiction
- Etiology
How to Cite
References
Ruetsch C. Empirical view of opioid dependence. J Manag Care Pharm. 2010;16(1):9-13.
Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):567-657.
Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15(7):556-62.
Jan SA. Introduction: landscape of opioid dependence. J Manag Care Pharm. 2010;16(1):4-8.
LeMoal M, Koob GF. Drug addiction: Pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol. 2007;17:377-93.
Mohammadi A, Darabi M, Nasry M, Sabet-Jahromi MJ, Malekpourafshar R, Sheibani H. Effect of opium addiction on lipidprofile and atherosclerosis formation in hypercholestrplemicrabbits. Exp and Tox Path. 2009;61:145-9.
Asadi-karam GR, Rashidianejad HR, Aghaee MM, Ahmadi J, Rahmani MR, Mohamadi M, et al. Opium can differently alterblood glucose, sodium and potassium inmale and female rats. Pak J Pharm Sci. 2008;28:180-4.
Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981-5.
Mitra S. Opioid-induced hyperalgesia: pathophysiology and clinical implications. J Opioid Manag. 2008;4(3):123-30.
Mami S, Eghbali M, Khosravi A, PourmehdiBM, Salati AP, Mami F, et al. Effect of opium addiction on T4,T3 and TSH in male and female rats. J Ilam Univ Med Sci. 2012;2:17-22.
Shavakhy A, Sadeghi AR, Minakary M. Opium consumption and risk of liverfibrosis in chronic hepatitis B and C. J Isfahan Med Sch. 2010;110:451-8.
Atici S, Cinel L, Doruk N, Eskandari G, Oral U. Liver and kidney toxicity in chronicuse of opioids: an experimental long termtreatment model. J Biosci. 2005;30:245-52.
Pappagallo M. Incidence, prevalence, andmanagement of opioid bowel dysfunction. Am J Surg. 2001;182(5A Suppl):11-18.
Zylberberg H, Fontaine H, Correas JM, Carnot F, BrechotC, Pol S. Dilated bile duct in patients receiving narcoticsubstitution: an early report. J Clin Gastroenterol. 2000;31:159-61.
Chuah SY, Leong CK, Pang CW. Dilated common bile ductin opium addicts with and without biliary symptoms--implication for research in AIDS cholangiopathy. Singapore Med J. 2003;44:261-7.
Choung RS, Locke GR , Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009;104(5):1199-204.
Malekzadeh MM, Khademi H, Pourshams A, Etemadi A, Poustchi H, Bagheri M, et al. Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol. 2013;108(11):1757-65.
Ahmadi B, Arab P, Zahedi MJ, Shafieipour S, Drossman DA, Banivaheb G. Prevalence of narcotic bowel syndrome in opioid abusers in Iran. Middle East J Dig Dis. 2014;6(4):208-13.
- Abstract Viewed: 452 times
- PDF Downloaded: 301 times